NSETrading Window18h ago · 15 Sept 2026, 08:00 pm

Trading Window

Arvee Laboratories (India) Limited · ARVEE

✦ AI Summary

Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed from 1st October, 2026, and will remain closed till next 2 working days of the exchange after the declaration of results for the period ended on 30th September, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

ARVEE_15092026195926_letter_for_Trading_Windows.pdf

pdf

Download →
View document text
ARVEE LABORATORIES (INDIA) LIMITED Registered Address: 403, Entice, Nr. Jayantilal Park BRTS, Iskcon-Bopal Road, Ambli, Ahmedabad, Gujarat - 380058 compliance@arveelabs.com CIN: L24231GJ2012PLC068778 www.arveelabs.com, Tel: 91- 2717-430479 =============================================================== Date: 15th September, 2026 National Stock Exchange of India Limited Mumbai Scrip Code: ARVEE Dear Sir/Ma’am, Subject: Intimation for Closure of Trading Window We would like to inform that the trading window for dealing in the securities of the Company will be closed from 1st October, 2026 and will remain closed till next 2 working days of the exchange after the declaration of results for the period ended on 30th September, 2026 for designated persons as per the Company’s Code of Conduct framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended. Accordingly, Promoters, Directors, Key Managerial Personnel and Designated Persons and their immediate relatives are requested to take note of the same and not to enter into any transaction involving the securities or deal in securities of the Company during the aforesaid period of closure of Trading Window. Thanking you, Yours Faithfully, For, Arvee Laboratories (India) Limited Shalin Patel Managing Director DIN: 01779902